The Study of Anti-CD19 CAR NK Cells in the Treatment of Relapsed/Refractory Diffuse Large B Cell Lymphoma
Clinical trial NCT05673447 · UNKNOWN
Trial details
- NCT number
- NCT05673447
- Sponsor
- Changhai Hospital
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-01
- Primary completion
- 2023-12-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.